|1.||Leino, Lasse: 6 articles (07/2014 - 03/2009)|
|2.||Laihia, Jarmo K: 5 articles (07/2014 - 11/2009)|
|3.||Reeve, Vivienne E: 4 articles (04/2010 - 10/2002)|
|4.||Domanski, Diane: 4 articles (04/2010 - 10/2002)|
|5.||Pylkkänen, Liisa: 3 articles (07/2014 - 11/2009)|
|6.||Kammeyer, Arthur: 3 articles (01/2012 - 03/2003)|
|7.||Allanson, Munif: 3 articles (04/2010 - 06/2009)|
|8.||Norval, M: 3 articles (02/2002 - 04/2001)|
|9.||Zare, Davood: 2 articles (08/2013 - 09/2012)|
|10.||Muhammad, Kharidah: 2 articles (08/2013 - 09/2012)|
|1.||Atopic Dermatitis (Atopic Eczema)
07/01/2014 - "Three randomised phase I/IIa trials of 5% cis-urocanic acid emulsion cream in healthy adult subjects and in patients with atopic dermatitis."
10/01/2014 - "Lipoxin A4, an eicosanoid with anti-inflammatory properties, and a 5% cis-urocanic acid emulsion cream were effective in the treatment of atopic dermatitis, although studies were small. "
01/01/2012 - "Breakdown products of filaggrin were quantified in tape-stripped stratum corneum from 31 atopic dermatitis patients and urocanic acid showed a positive correlation with total copy number. "
01/01/2004 - "Growing evidence suggests an impaired release of proton donors, such as amino acids, urocanic acid, and lactic acid, to the stratum corneum in atopic dermatitis, as a result of reductions in filaggrin proteolysis and sweat secretion. "
01/01/2010 - "In conclusion, this study demonstrates that cis-urocanic acid is effective in reducing the severity of colitis in a chemically-induced mouse model, indicating that pathways induced by ultraviolet radiation to the skin can influence distal sites of inflammation. "
09/01/2012 - "Topical cis-urocanic acid attenuates oedema and erythema in acute and subacute skin inflammation in the mouse."
03/01/2009 - "To evaluate the effects of cis-urocanic acid (cis-UCA) on mammary gland (MG) inflammation and injury associated with Escherichia coli-induced mastitis in dairy cows. "
03/01/2009 - "Effects of intramammary infusion of cis-urocanic acid on mastitis-associated inflammation and tissue injury in dairy cows."
10/01/2001 - "cis-Urocanic-acid-induced neuropeptides may also contribute to ultraviolet-B-induced cutaneous inflammation and alterations to Langerhans cell activity."
01/01/2015 - "A recent patent deals with the utilization of cis-Urocanic acid to acidify the pHi and induce apoptosis in tumors. "
04/01/2012 - "All tumors detected in animals treated with vehicle were muscle invasive (stage T2 or greater) but only 43% of tumors were muscle invasive in the cis-urocanic acid treated group (p=0.049). "
12/01/2001 - "The photoisomer of urocanic acid (UCA), cis-UCA, is an important mediator of UV-induced immunosuppression and is involved in the inhibition of tumor immunity. "
07/01/1997 - "Regulation of tumor antigen presentation by urocanic acid."
01/01/1985 - "Urocanic acid inhibited the protein synthesis in tumoral cells at the step of translation, retarding growth of various strains of transferring tumors in mice. "
|5.||Urinary Bladder Neoplasms (Bladder Cancer)
04/01/2012 - "Cis-urocanic acid showed direct antiproliferative activity against rat bladder cancer cells in vitro and antitumor effects in vivo. "
04/01/2012 - "The rat bladder cancer cell line AY-27 was exposed to cis-urocanic acid (BioCis Pharma, Turku, Finland) at pH 6.5 or 7.4 for 2 hours. "
11/01/2009 - "To present a novel treatment approach for urinary bladder cancer, protodynamic therapy, which comprises inhibition of cancer cell proliferation by intracellular acidification; cis-urocanic acid (cis-UCA) was investigated as a protodynamic drug in bladder cancer cell cultures and compared with conventional chemotherapeutic agents. "
04/01/2012 - "We investigated cis-urocanic acid in rat bladder cancer cell cultures and in an orthotopic rat urothelial carcinoma model to assess its safety and antiproliferative activity. "
|4.||Interleukin-10 (Interleukin 10)
|5.||Interleukin-6 (Interleukin 6)
|9.||5'- O- (6- O- malonylglucopyranosyl)pyridoxine
|1.||Transplantation (Transplant Recipients)
|3.||Homologous Transplantation (Allograft)
|4.||Phototherapy (Light Therapy)